Autoimmunity, Non-Classic Adrenal Hyperplasia, Insulin Resistance, and Vitamin D
References
Sacerdote AS. Adrenal androgens and NIDDM. Diabetes Care 1995; 18(2): 278-9. https://doi.org/10.2337/diacare.18.2.278b
Bahtiyar G, Sacerdote A. Latest Therapeutic Advances in the Treatment of Congenital Adrenal Hyperplasia in Adolescents and Adults. In “Amenorrhea; publisher-Intech.
Sacerdote A, Bahtiyar G (2015). Treatment of Congenital Adrenal Hyperplasia by Reducing Insulin Resistance and Cysticercosis Induced Polycystic Ovarian Syndrome, Contemporary Gynecologic Practice, Prof. Atef Darwish (Ed.), ISBN: 978-953-51-1736- 0, InTech, Available from: http://www.intechopen.com/books/contemporary-gynecologic-practice/treatment-of-congenital-adrenal-hyperplasia-by-reducinginsulin-resistance-and-cysticercosis-induced-Published on line 11-2011; published in print 12-2011.
Sacerdote A. The expanding universe of androgenic disorders; Guest Editorial in Endocrine Today 2005; 3(2): 4-7.
Sacerdote A. Adrenal Hyperandrogenemia in IDDM. Program and Abstracts, 77th Annual Meeting of The Endocrine Society 1995; 545, (poster presentation).
Itariu BK, Stulnig TM. Autoimmune aspects of type 2 diabetes mellitus - a mini-review. Gerontology 2014; 60(3): 189-96. https://doi.org/10.1159/000356747
Sacerdote A. Adrenal Hyperandrogenemia in Graves’ Disease. Program and Abstracts, Tenth International Congress of Endocrinology II: 1000, 1996 (poster presentation).
Sacerdote A. Adrenal Hyperandrogenemia in Hashimoto’s Thyroiditis. Program and Abstracts, Tenth International Congress of Endocrinology II: 1000, 1996 (poster presentation).
Sacerdote A, Li Y. Adrenal Hyperandrogenemia in Psoriasis. Program and Abstracts, 79th Annual Meeting of The Endocrine Society 1997; 310. (poster presentation).
Sacerdote A. Vitiligo Is Associated with Adrenal Hyperandrogenemia. Program and Abstracts, 80th Annual Meeting of The Endocrine Society 1998; 199, (poster presentation).
Sacerdote AS, Bahtiyar G, Mejía J. Rheumatoid arthritis is associated with non-classical adrenal hyperplasia. Program and Abstracts, Endo 2007, 89th Annual Meeting of The Endocrine Society 2007; 672, (poster presentation).
Chen W, Kim MS, Shanbhag S, Arai A, VanRyzin C, McDonnell NB, Merke DP. The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects. Am J Med Genet A 2009; 149A(12): 2803-8. https://doi.org/10.1002/ajmg.a.33092
Olaisen B, Teisberg P, Nordhagen R, et al. Human complement C4 locus is duplicated on some chromosomes. Nature 1979; 279: 736-737. https://doi.org/10.1038/279736a0
Sacerdote A, Weiss K, Polanco H, Fermin E, Hussain S. Atypical and Typical Antipsychotics, Divalproex, and Valproic Acid Use are Associated with Adrenal Hyperandrogenemia. Program and Abstracts, Endo 2004, the 86th Annual Meeting of The Endocrine Society 649, 2004 (poster presentation).
Bahtiyar G, Weiss K, Sacerdote A. Novel endocrine disrupter effects of anti-psychotic drugs and valproate; Induction of adrenal hyperandrogenism; Reversibility with Insulin Sensitizers. Endocrine Practice 2007; 13(6): 601-608. Am J Med Genet A 2009; 149A(12): 2803-2808.
Speiser PW, Serrat J, New MI, Gertner JM Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992; 75(6): 1421-4.
Saygili F, Oge A, Yilmaz C. Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Horm Res 2005; 63(6): 270-4.
Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 2002; 87(5): 2114-20. https://doi.org/10.1210/jcem.87.5.8456
Atabek ME, Kurtoğlu S, Keskin M. Female pseudohermaphroditism due to classical 21-hydroxylase deficiency and insulin resistance in a girl with Turner syndrome. Turk J Pediatr 2005; 47(2): 176-9.
Bahtiyar G, Weiss K, Sacerdote A. Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone. Endocrine Practice 2008; 13(6): 601-8. https://doi.org/10.4158/EP.13.6.601
Thomas A, Kalani A, Vincent R, Luis-Lam M, Bahtiyar G, Borensztein A, Quinto E, Sacerdote A. Effect of Vitamin D in a patient with classical adrenal hyperplasia due to 11- hydroxylase deficiency. J Med Cases 2013; 4(8): 569-75. https://doi.org/10.4021/jmc1352w
Fenteany G, Inoue T, Bahtiyar G, Sacerdote AS. Association of Vitamin D repletion with normalization of elevated serum 17-OH-progesterone. Med Cas Rep 2017; 3: 3.
Osehobo E, Sacerdote, A. Aldosterone Synthase Deficiency; A Newly Described Variant of Non-Classical Congenital Adrenal Hyperplasia. Program and Abstracts, 81st Annual Meeting of The Endocrine Society, 1999 (poster presentation).
Sacerdote A. Weight-Dependent Expression of Non-Classical Aldosterone Synthase Deficiency. And Abstracts, Endo-2002, The Endocrine Society’s 84th Annual Meeting 2002; 599.
Sacerdote A, Girgis E, Toossi A, Polanco H, Bahtiyar G. Additional endocrine disrupter effects of highly active anti-retroviral treatment-induction of non-classical adrenal hyperplasia. Program and Abstracts, Endo 2006 88th Annual meeting of The Endocrine Society 202, 2006 (poster presentation).
Kalani A, Thomas N, Sacerdote A, Bahtiyar G. Roux-en-Y gastric bypass in the treatment of non-classic congenital adrenal hyperplasia due to 11-hydroxylase deficiency. BMJ Case Rep 2013; 2013.
Baby A, Inoue T, Ezeji G, Giunta J, Bahtiyar G, Sacerdote AS. Ashwagandha Root in the Treatment of Non-Classic 11-Hydroxylase Deficiency Program: Abstracts - Orals, Poster Previews, and Posters Session: THR 402-416-Congenital Adrenal Hyperplasia Clinical Thursday, March 5, 2015: 1: 00 PM-3: 00 PM Hall D-F, Adrenal (San Diego Convention Center) Poster Board THR-416.
Powell D, Inoue T, Bahtiyar G, Fenteany G, Sacerdote A. Treatment of Nonclassic 11-Hydroxylase Deficiency with Ashwagandha Root. Case Rep Endocrinol 2017; 2017: 1869560.
Inoue T, Soni L, Bahlol M, Fenteany G, Bahtiyar G, Sacerdote A. Worsening and Prolonged Hypovitaminosis D is Associated with Biochemical Exacerbation of Non-classic 11-Hydroxylase Deficiency. Presented at Endo 2018, Chicago, IL Mar 17-20, 2018.
Krysiak R, Kowalcze K, Bednarska-Czerwińska A, Okopień B. The effect of simvastatin on plasma steroid hormone levels in metformin-treated women with non-classic congenital adrenal hyperplasia. Exp Clin Endocrinol Diabetes 2016; 124(4): 215-9. https://doi.org/10.1055/s-0035-1569375
Tomczynska M, Bijak M, Saluk J. Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug. Curr Top Med Chem 2016; 16(19): 2223-30. https://doi.org/10.2174/1568026616666160216152324
Negrotto L, Farez MF, Correale J. Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis. JAMA Neurol 2016; 73(5): 520-8. https://doi.org/10.1001/jamaneurol.2015.4807
Bubna AK. Metformin - For the dermatologist. Indian J Pharmacol 2016; 48(1): 4-10. https://doi.org/10.4103/0253-7613.174388
Wang H, Li T, Chen S, Gu Y, Ye S. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Arthritis Rheumatol 2015; 67(12): 3190-200. https://doi.org/10.1002/art.39296
Krysiak R, Szkrobka W, Okopien B. The Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Women with Interferon-Induced Hypothyroidism: A Pilot Study. Exp Clin Endocrinol Diabetes 2016; 124(2): 71-6. https://doi.org/10.1055/s-0035-1565207
Wada K, Kamisaki Y. [Anti-inflammatory effect of PPAR gamma agonists: basics and clinical applications]. Nihon Rinsho 2010; 68(2): 278-83.
Rousseaux C, Desreumaux P. The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)]. J Soc Biol 2006; 200(2): 121-31. https://doi.org/10.1051/jbio:2006015
Malhotra A, Shafiq N, Rajagopalan S, Dogra S, Malhotra S. Thiazolidinediones for plaque psoriasis: a systematic review and meta-analysis. Evid Based Med 2012; 17(6): 171-6. https://doi.org/10.1136/ebmed-2011-100388
Jensen P, Christensen R, Zachariae C, Geiker NR, Schaadt BK, Stender S, Hansen PR, Astrup A, Skov L. Long-term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow-up study. Am J Clin Nutr 2016; 104(2): 259-65. https://doi.org/10.3945/ajcn.115.125849
Sparks JA, Halperin F, Karlson JC, Karlson EW, Bermas BL. Impact of Bariatric Surgery on Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2015; 67(12):
-26. https://doi.org/10.1002/acr.22629
Kumar G, Srivastava A, Sharma SK, Rao TD, Gupta YK. Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study. Indian J Med Res 2015; 141(1): 100-6. https://doi.org/10.4103/0971-5916.154510
Schwalfenberg GK. Solar Radiation and Vitamin D: Mitigating Environmental Factors in Autoimmune Disease. Journal of Environmental and Public Health Volume 2012 (2012), Article ID 619381. https://doi.org/10.1155/2012/619381
Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 2013; 45(2): 256-66. https://doi.org/10.1007/s12016-012-8342-y
Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009; 4(8): e6635.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar. CADTH Rapid Response Reports. Vitamin D for the Treatment or Prevention of Multiple Sclerosis: A Review of the Clinical Effectiveness.
Brola W, Sobolewski P, Szczuchniak W, Góral A, Fudala M, Przybylski W, Opara J. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis. Eur J Clin Nutr 2016; 70(9): 995-9. https://doi.org/10.1038/ejcn.2016.51
Muscogiuri G, Mitri J2, Mathieu C, Badenhoop K, Tamer G, Orio F, Mezza T, Vieth R, Colao A, Pittas A. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur J Endocrinol 2014; 171(3): R101-10.
Kamen DL. Vitamin D in lupus - new kid on the block? Bull NYU Hosp Jt Dis 2010; 68(3): 218-22.
Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 2012; 12(2): 127-36. https://doi.org/10.1016/j.autrev.2012.07.007
Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 2013; 40(3): 265-72. https://doi.org/10.3899/jrheum.111594
Bright JJ. Curcumin and autoimmune disease. Adv Exp Med Biol 2007; 595: 425-51. https://doi.org/10.1007/978-0-387-46401-5_19
Laura J. McCreight, Clifford J. Bailey, and Ewan R. Pearson. Metformin and the gastrointestinal tract. Diabetologia 2016; 59: 426-435. https://doi.org/10.1007/s00125-015-3844-9
Peat CM, Kleiman SC, Bulik CM, Carroll IM. The intestinal microbiome in bariatric surgery patients. Eur Eat Disord Rev 2015; 23(6): 496-503. https://doi.org/10.1002/erv.2400
De Groot PF, Frissen MN, De Clercq NC, Nieuwdorp M. Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes 2017; 8(3): 253-267. https://doi.org/10.1080/19490976.2017.1293224
Kootte RS, Levin E, Salojärvi J, Smits LP, Hartstra AV, Udayappan SD, Hermes G, Bouter KE, Koopen AM, Holst JJ, Knop FK, Blaak EE, Zhao J, Smidt H, Harms AC, Hankemeijer T, Bergman JJGHM, Romijn HA, Schaap FG, Olde Damink SWM, Ackermans MT, Dallinga-Thie GM, Zoetendal E, de Vos WM, Serlie MJ, Stroes ESG, Groen AK, Nieuwdorp M. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab 2017; 26(4): 611-619. https://doi.org/10.1016/j.cmet.2017.09.008
